UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2007. Commission File Number 1-14840 AMDOCS LIMITED Suite 5, Tower Hill House Le Bordage St. Peter Port, Island of Guernsey, GY1 3QT Channel Islands Amdocs, Inc. 1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. FORM 20-F [X} FORM 40-F [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ] Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to rule 12g3-2(b) under the Securities Exchange Act of 1934. YES [ ] NO [X]
On April 26, 2007, Amdocs Limited ("Amdocs") issued a press release announcing financial results for the quarter ended March 31, 2007. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K. The information in this Form 6-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AMDOCS LIMITED /s/ Thomas G. O'Brien ------------------------------ Thomas G. O'Brien Treasurer and Secretary Authorized U.S. Representative Date: April 27, 2007
EXHIBIT INDEX EXHIBIT NO. DESCRIPTION - ----------- ----------- 99.1 Amdocs Limited Press Release dated April 26, 2007.
Exhibit 99.1 AMDOCS LIMITED REPORTS RECORD REVENUE OF $706 MILLION AMDOCS REPORTS 18% GROWTH IN QUARTERLY DILUTED NON-GAAP EARNINGS PER SHARE TO $0.52; DILUTED GAAP EARNINGS PER SHARE OF $0.40 Key highlights: - Second quarter revenue increased 18% to $706 million - 18% increase in second quarter diluted non-GAAP EPS, excluding acquisition-related costs, restructuring charges and equity-based compensation expense, net of related tax effects, to $0.52 - Diluted GAAP EPS of $0.40 - Amdocs was awarded a significant managed services contract by AT&T - Acquisition of SigValue Technologies, Inc. expands Amdocs offering for fast-growing emerging markets - Third quarter fiscal 2007 guidance: Expected revenue of approximately $710-$720 million and diluted non-GAAP EPS of $0.50 - $0.52, excluding acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.38-$0.41 - Reiterated fiscal 2007 guidance: Expected revenue of approximately $2.83-$2.91 billion and diluted non-GAAP EPS of $2.02-$2.12, which exclude acquisition-related costs, restructuring charges and approximately $0.21-$0.24 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $1.54-$1.68 ST. LOUIS, MO - APRIL 26, 2007 - Amdocs Limited (NYSE: DOX) today reported that for the quarter ended March 31, 2007, revenue was $706.4 million, an increase of 17.5% from last year's second quarter. Net income on a non-GAAP basis was $114.5 million, or $0.52 per diluted share (excluding acquisition-related costs, which include amortization of purchased intangible assets, in-process research and development write-off and other, and excluding restructuring charges and equity-based compensation expense, net of related tax effects, of $27.3 million), compared to non-GAAP net income of $95.5 million, or $0.44 per diluted share, in the second quarter of fiscal 2006 (excluding acquisition-related costs, which include amortization of purchased intangible assets, and equity-based compensation
expense, net of related tax effects, of $13.8 million). The Company's GAAP net income was $87.2 million, or $0.40 per diluted share, compared to GAAP net income of $81.8 million, or $0.38 per diluted share, in the second quarter of fiscal 2006. Free cash flow for the quarter was $57.9 million, comprised of cash flow from operations of $91.2 million less $33.3 million in net capital expenditures. "We are pleased to report another successful quarter for Amdocs as we continue to execute," said Dov Baharav, chief executive officer of Amdocs Management Limited. "Revenue is at record levels and earnings growth is strong. During the quarter we formally launched our Amdocs 7 suite of products which are generating wins for Amdocs. We are delivering solutions and therefore we are expanding our relationship with key customers as they transform their businesses to address convergence, competition and consolidation. While the timing of individual projects can be difficult to predict, the ongoing trend is clear. Transformation activity is driving demand for our products and services today and should provide Amdocs with growth opportunities for years to come." Amdocs new business included a variety of wins across geographies and lines of business. These wins include an important managed services contract with AT&T to provide application management services in support of their legacy ordering and wholesale platforms, including software development, testing and production support. In the broadband cable and satellite market, the Company's wins included subscriber conversions onto an Amdocs system. For an existing customer in Europe, Amdocs has been engaged to provide a CRM solution for multiple market segments. Amdocs continues to grow its OSS business with projects including license and services for customers around the globe, including several new logos. At the end of its first fiscal quarter, the Company projected that its diluted GAAP EPS for the fiscal quarter ending March 31, 2007 would be $0.35 to $0.39. The Company anticipated that its non-GAAP EPS would be $0.49 to $0.51, excluding acquisition-related costs (which include amortization of purchased intangible assets, in-process research and development write-off and other), and excluding restructuring charges and equity-based compensation expense, net of related tax effects. As reported, GAAP EPS per diluted share for the second quarter of fiscal 2007 was $0.40. Non-GAAP EPS per diluted share was $0.52 for the quarter, excluding acquisition-related
costs (which include amortization of purchased intangible assets, in-process research and development write-off and other), and excluding restructuring charges and equity-based compensation expense, net of related tax effects. The excluded pre-tax restructuring charges amounted to approximately $6 million, reducing GAAP EPS per diluted share by $0.02. The charges consist primarily of severance and other employment related obligations incurred in connection with Amdocs' measures designed to align its operational structure to it expected future growth and to improve efficiency. FINANCIAL OUTLOOK Amdocs expects that revenue for the third quarter of fiscal 2007 will be approximately $710-$720 million. Diluted earnings per share on a non-GAAP basis for the third quarter are expected to be $0.50-$0.52, excluding acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.38-$0.41. Reiterated fiscal 2007 guidance: Expected revenue of approximately $2.83-$2.91 billion and diluted non-GAAP EPS of $2.02-$2.12, which excludes acquisition-related costs, restructuring charges and approximately $0.21-$0.24 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $1.54-$1.68. Amdocs will host a conference call on April 26, 2007 at 5 p.m. Eastern Time to discuss the Company's second quarter results. The call will be carried live on the Internet via www.InvestorCalendar.com and the Amdocs website, www.amdocs.com. NON-GAAP FINANCIAL MEASURES This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP income taxes and non-GAAP net income. These non-GAAP measures exclude the following items:
- amortization of purchased intangible assets; - in-process research and development write-off and other; - restructuring charges; - equity-based compensation expense; and - tax effects related to the above. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures. Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP income taxes and non-GAAP net income, when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business. For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets, in-process research and development write-off and other, restructuring charges, equity-based compensation expense, and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these non-cash expenses in reviewing its results and those of its competitors, because the amounts of the expenses between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the expenses.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below. ABOUT AMDOCS Amdocs combines innovative software and services with deep business knowledge to accelerate implementation of integrated customer management by the world's leading service providers. By delivering a comprehensive portfolio of software and services that spans the customer lifecycle, Amdocs enables service companies to deliver an intentional customer experienceTM, which results in stronger, more profitable customer relationships. Service providers also benefit from a rapid return on investment, lower total cost of ownership and improved operational efficiencies. A global company with revenue of $2.48 billion in fiscal 2006, Amdocs has over 16,000 employees and serves customers in more than 50 countries around the world. For more information, visit Amdocs at www.amdocs.com. This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks
associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2006, filed on December 13, 2006 and in our quarterly Form 6-K furnished on February 6, 2007. CONTACT: Thomas G. O'Brien Treasurer and Vice President of Investor Relations Amdocs Limited 314-212-8328 E-mail: dox_info@amdocs.com
AMDOCS LIMITED CONSOLIDATED STATEMENTS OF INCOME (IN THOUSANDS, EXCEPT PER SHARE DATA) THREE MONTHS ENDED SIX MONTHS ENDED MARCH 31, MARCH 31, ------------------- ----------------------- 2007 2006 2007 2006 -------- -------- ---------- ---------- Revenue: License $ 37,526 $ 30,291 $ 69,270 $ 61,952 Service 668,835 570,838 1,328,123 1,126,205 -------- -------- ---------- ---------- 706,361 601,129 1,397,393 1,188,157 Operating expenses: Cost of license 1,016 916 2,085 1,978 Cost of service 446,860 388,333 881,981 762,384 Research and development 57,734 41,823 118,202 84,937 Selling, general and administrative 91,280 73,799 180,450 152,349 Amortization of purchased intangible assets 18,912 7,469 36,610 15,041 Restructuring charges, in-process research and development and other (1) 6,761 -- 6,761 -- -------- -------- ---------- ---------- 622,563 512,340 1,226,089 1,016,689 -------- -------- ---------- ---------- Operating income 83,798 88,789 171,304 171,468 Interest income and other, net 10,899 10,307 22,638 18,721 -------- -------- ---------- ---------- Income before income taxes 94,697 99,096 193,942 190,189 Income taxes 7,526 17,334 13,429 33,093 -------- -------- ---------- ---------- Net income $ 87,171 $ 81,762 $ 180,513 $ 157,096 ======== ======== ========== ========== Basic earnings per share $ 0.42 $ 0.40 $ 0.87 $ 0.78 ======== ======== ========== ========== Diluted earnings per share (2) $ 0.40 $ 0.38 $ 0.82 $ 0.74 ======== ======== ========== ========== Basic weighted average number of shares outstanding 207,293 202,515 206,867 201,509 ======== ======== ========== ========== Diluted weighted average number of shares outstanding 222,499 217,919 222,608 216,394 ======== ======== ========== ========== (1) Restructuring charges, in-process research and development and other for the three and six months ended March 31, 2007 include the following: restructuring charges of $6,011, in-process research and development of $2,666 offset by other acquisition related income of $1,916. (2) To reflect the impact of assumed conversion of the convertible notes, $985 and $1,970, representing interest expense and amortization of issuance costs, were added back to net income for the three and six months ended March 31, 2007, respectively, and $979 and $1,979 were added back to net income for the three and six months ended March 31, 2006, respectively, for the purpose of computing diluted earnings per share.
AMDOCS LIMITED SELECTED FINANCIAL METRICS (IN THOUSANDS, EXCEPT PER SHARE DATA) THREE MONTHS ENDED SIX MONTHS ENDED MARCH 31, MARCH 31, ------------------- ----------------------- 2007 2006 2007 2006 -------- -------- ---------- ---------- Revenue $706,361 $601,129 $1,397,393 $1,188,157 Non-GAAP operating income 121,437 106,198 241,966 207,509 Non-GAAP net income 114,471 95,534 232,587 185,509 Non-GAAP diluted earnings per share (1) $ 0.52 $ 0.44 $ 1.05 $ 0.87 Diluted weighted average number of shares outstanding 222,499 217,919 222,608 216,394 (1) To reflect the impact of assumed conversion of the convertible notes, $985 and $1,970, representing interest expense and amortization of issuance costs, were added back to net income for the three and six months ended March 31, 2007, respectively, and $979 and $1,979 were added back to net income for the three and six months ended March 31, 2006, respectively, for the purpose of computing diluted earnings per share.
AMDOCS LIMITED RECONCILIATION OF SELECTED FINANCIAL METRICS FROM GAAP TO NON-GAAP (IN THOUSANDS) THREE MONTHS ENDED MARCH 31, 2007 ---------------------------------------------------------------------------------- RECONCILIATION ITEMS ------------------------------------------------------------ RESTRUCTURING AMORTIZATION CHARGES, IN-PROCESS OF PURCHASED RESEARCH AND EQUITY BASED INTANGIBLE DEVELOPMENT AND COMPENSATION TAX GAAP ASSETS OTHER EXPENSE EFFECT NON-GAAP -------- ------------ ------------------- ------------ -------- -------- Operating expenses: Cost of license $ 1,016 $ -- $ -- $ -- $ -- $ 1,016 Cost of service 446,860 -- -- (6,005) -- 440,855 Research and development 57,734 -- -- (1,587) -- 56,147 Selling, general and administrative 91,280 -- -- (4,374) -- 86,906 Amortization of purchased intangible assets 18,912 (18,912) -- -- -- -- Restructuring charges, in-process research and development and other 6,761 -- (6,761) -- -- -- -------- -------- ------- -------- -------- -------- Total operating expenses 622,563 (18,912) (6,761) (11,966) -- 584,924 -------- -------- ------- -------- -------- -------- Operating income 83,798 18,912 6,761 11,966 -- 121,437 -------- -------- ------- -------- -------- -------- Income taxes 7,526 -- -- -- 10,339 17,865 -------- -------- ------- -------- -------- -------- Net income $ 87,171 $ 18,912 $ 6,761 $ 11,966 $(10,339) $114,471 -------- -------- ------- -------- -------- -------- THREE MONTHS ENDED MARCH 31, 2006 ----------------------------------------------------------- RECONCILIATION ITEMS ------------------------------------- AMORTIZATION OF PURCHASED EQUITY BASED INTANGIBLE COMPENSATION TAX GAAP ASSETS EXPENSE EFFECT NON-GAAP -------- ------------ ------------ ------- -------- Operating expenses: Cost of license $ 916 $ -- $ -- $ -- $ 916 Cost of service 388,333 -- (3,717) -- 384,616 Research and development 41,823 -- (720) -- 41,103 Selling, general and administrative 73,799 -- (5,503) -- 68,296 Amortization of purchased intangible assets 7,469 (7,469) -- -- -- -------- ------- ------- ------- -------- Total operating expenses 512,340 (7,469) (9,940) -- 494,931 -------- ------- ------- ------- -------- Operating income 88,789 7,469 9,940 -- 106,198 -------- ------- ------- ------- -------- Income taxes 17,334 -- -- 3,637 20,971 -------- ------- ------- ------- -------- Net income $ 81,762 $ 7,469 $ 9,940 $(3,637) $ 95,534 -------- ------- ------- ------- --------
AMDOCS LIMITED RECONCILIATION OF SELECTED FINANCIAL METRICS FROM GAAP TO NON-GAAP (IN THOUSANDS) SIX MONTHS ENDED MARCH 31, 2007 -------------------------------------------------------------------------------------- RECONCILIATION ITEMS ------------------------------------------------------------ RESTRUCTURING AMORTIZATION CHARGES, IN-PROCESS OF PURCHASED RESEARCH AND EQUITY BASED INTANGIBLE DEVELOPMENT AND COMPENSATION TAX GAAP ASSETS OTHER EXPENSE EFFECT NON-GAAP ---------- ------------ ------------------- ------------ -------- ---------- Operating expenses: Cost of license $ 2,085 $ -- $ -- $ -- $ -- $ 2,085 Cost of service 881,981 -- -- (12,327) -- 869,654 Research and development 118,202 -- -- (3,365) -- 114,837 Selling, general and administrative 180,450 -- -- (11,599) -- 168,851 Amortization of purchased intangible assets 36,610 (36,610) -- -- -- -- Restructuring charges, in-process research and development and other 6,761 -- (6,761) -- -- -- ---------- -------- ------- -------- -------- ---------- Total operating expenses 1,226,089 (36,610) (6,761) (27,291) -- 1,155,427 ---------- -------- ------- -------- -------- ---------- Operating income 171,304 36,610 6,761 27,291 -- 241,966 ---------- -------- ------- -------- -------- ---------- Income taxes 13,429 -- -- -- 18,588 32,017 ---------- -------- ------- -------- -------- ---------- Net income $ 180,513 $ 36,610 $ 6,761 $ 27,291 $(18,588) $ 232,587 ---------- -------- ------- -------- -------- ---------- SIX MONTHS ENDED MARCH 31, 2006 ----------------------------------------------------------- RECONCILIATION ITEMS ------------------------------------- AMORTIZATION OF PURCHASED EQUITY BASED INTANGIBLE COMPENSATION TAX GAAP ASSETS EXPENSE EFFECT NON-GAAP ---------- ------------ ------------ ------- -------- Operating expenses: Cost of license $ 1,978 $ -- $ -- $ -- $ 1,978 Cost of service 762,384 -- (8,072) -- 754,312 Research and development 84,937 -- (1,809) -- 83,128 Selling, general and administrative 152,349 -- (11,119) -- 141,230 Amortization of purchased intangible assets 15,041 (15,041) -- -- -- ---------- -------- -------- ------- -------- Total operating expenses 1,016,689 (15,041) (21,000) -- 980,648 ---------- -------- -------- ------- -------- Operating income 171,468 15,041 21,000 -- 207,509 ---------- -------- -------- ------- -------- Income taxes 33,093 -- -- 7,628 40,721 ---------- -------- -------- ------- -------- Net income $ 157,096 $ 15,041 $ 21,000 $(7,628) $185,509 ---------- -------- -------- ------- --------
AMDOCS LIMITED CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS) AS OF -------------------------- MARCH 31, SEPTEMBER 30, 2007 2006 ---------- ------------- ASSETS Current assets Cash, cash equivalents and short-term interest-bearing investments $1,039,435 $ 979,381 Accounts receivable, net, including unbilled of $57,977 and $54,117 respectively 476,224 425,805 Deferred income taxes and taxes receivable 113,650 136,044 Prepaid expenses and other current assets 99,259 97,476 ---------- ---------- Total current assets 1,728,568 1,638,706 Equipment, vehicles and leasehold improvements, net 242,784 220,290 Goodwill and other intangible assets, net 1,838,383 1,809,322 Other noncurrent assets 352,282 294,510 ---------- ---------- Total assets $4,162,017 $3,962,828 ========== ========== LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities Accounts payable and accruals $ 555,573 $ 597,107 Short-term portion of capital lease obligations and other financing arrangements 2,003 1,963 Deferred revenue 264,663 253,376 Deferred income taxes and taxes payable 176,368 179,241 ---------- ---------- Total current liabilities 998,607 1,031,687 0.50% Convertible notes 450,000 450,000 Noncurrent liabilities and other 317,824 326,976 Shareholders' equity 2,395,586 2,154,165 ---------- ---------- Total liabilities and shareholders' equity $4,162,017 $3,962,828 ========== ========== # # #